124 related articles for article (PubMed ID: 14577218)
1. Spectrofluorometric analysis of CYP2A6-catalyzed coumarin 7-hydroxylation.
Waxman DJ; Chang TK
Methods Mol Biol; 1998; 107():111-6. PubMed ID: 14577218
[No Abstract] [Full Text] [Related]
2. Novel sensitive high-performance liquid chromatographic method for assay of coumarin 7-hydroxylation.
Soucek P
J Chromatogr B Biomed Sci Appl; 1999 Oct; 734(1):23-9. PubMed ID: 10574186
[TBL] [Abstract][Full Text] [Related]
3. Spectrofluorometric analysis of CYP2A6-catalyzed coumarin 7-hydroxylation.
Waxman DJ; Chang TK
Methods Mol Biol; 2006; 320():91-6. PubMed ID: 16719377
[TBL] [Abstract][Full Text] [Related]
4. CYP2C19-mediated (S)-mephenytoin 4'-hydroxylation assayed by high-performance liquid chromatography with radiometric detection.
Crespi CL; Chang TK; Waxman DJ
Methods Mol Biol; 1998; 107():135-9. PubMed ID: 14577222
[No Abstract] [Full Text] [Related]
5. Ethnic-related differences in coumarin 7-hydroxylation activities catalyzed by cytochrome P4502A6 in liver microsomes of Japanese and Caucasian populations.
Shimada T; Yamazaki H; Guengerich FP
Xenobiotica; 1996 Apr; 26(4):395-403. PubMed ID: 9173680
[TBL] [Abstract][Full Text] [Related]
6. A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin.
Hadidi H; Zahlsen K; Idle JR; Cholerton S
Food Chem Toxicol; 1997 Sep; 35(9):903-7. PubMed ID: 9409631
[TBL] [Abstract][Full Text] [Related]
7. CYP2A6: a human coumarin 7-hydroxylase.
Pelkonen O; Rautio A; Raunio H; Pasanen M
Toxicology; 2000 Apr; 144(1-3):139-47. PubMed ID: 10781881
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
Draper AJ; Madan A; Parkinson A
Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
[TBL] [Abstract][Full Text] [Related]
9. Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6.
Hadidi H; Irshaid Y; Vågbø CB; Brunsvik A; Cholerton S; Zahlsen K; Idle JR
Eur J Clin Pharmacol; 1998 Jul; 54(5):437-41. PubMed ID: 9754990
[TBL] [Abstract][Full Text] [Related]
10. Regulation of coumarin 7-hydroxylation in man.
Pelkonen O; Rautio A; Raunio H; Mäenpää J; Hakkola J
J Cancer Res Clin Oncol; 1994; 120 Suppl():S30-1. PubMed ID: 8132700
[No Abstract] [Full Text] [Related]
11. Evidence for metabolic activation of N'-nitrosonornicotine and N-nitrosobenzylmethylamine by a rat nasal coumarin hydroxylase.
Patten CJ; Peterson LA; Murphy SE
Drug Metab Dispos; 1998 Feb; 26(2):177-80. PubMed ID: 9456305
[TBL] [Abstract][Full Text] [Related]
12. Comparison of "high throughput" micromethods for determination of cytochrome P450 activities with classical methods using HPLC for product identification.
Anzenbacherová E; Veinlichová A; Masek V; Anzenbacher P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):353-5. PubMed ID: 16601787
[TBL] [Abstract][Full Text] [Related]
13. CYP2A13-catalysed coumarin metabolism: comparison with CYP2A5 and CYP2A6.
von Weymarn LB; Murphy SE
Xenobiotica; 2003 Jan; 33(1):73-81. PubMed ID: 12519695
[TBL] [Abstract][Full Text] [Related]
14. A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502).
Nunoya K; Yokoi T; Kimura K; Inoue K; Kodama T; Funayama M; Nagashima K; Funae Y; Green C; Kinoshita M; Kamataki T
Pharmacogenetics; 1998 Jun; 8(3):239-49. PubMed ID: 9682269
[TBL] [Abstract][Full Text] [Related]
15. An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines its role in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole in human liver.
Sai Y; Yang TJ; Krausz KW; Gonzalez FJ; Gelboin HV
Pharmacogenetics; 1999 Apr; 9(2):229-37. PubMed ID: 10376770
[TBL] [Abstract][Full Text] [Related]
16. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers.
Rautio A; Kraul H; Kojo A; Salmela E; Pelkonen O
Pharmacogenetics; 1992 Oct; 2(5):227-33. PubMed ID: 1306122
[TBL] [Abstract][Full Text] [Related]
17. Coumarin metabolism by rat esophageal microsomes and cytochrome P450 2A3.
von Weymarn LB; Murphy SE
Chem Res Toxicol; 2001 Oct; 14(10):1386-92. PubMed ID: 11599930
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of neurotransmitters and steroids on human CYP2A6.
Higashi E; Nakajima M; Katoh M; Tokudome S; Yokoi T
Drug Metab Dispos; 2007 Apr; 35(4):508-14. PubMed ID: 17237153
[TBL] [Abstract][Full Text] [Related]
19. Single-dose disulfiram does not inhibit CYP2A6 activity.
Kharasch ED; Hankins DC; Baxter PJ; Thummel KE
Clin Pharmacol Ther; 1998 Jul; 64(1):39-45. PubMed ID: 9695717
[TBL] [Abstract][Full Text] [Related]
20. Metabolic interactions of methoxsalen and coumarin in humans and mice.
Mäenpää J; Juvonen R; Raunio H; Rautio A; Pelkonen O
Biochem Pharmacol; 1994 Oct; 48(7):1363-9. PubMed ID: 7945434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
